Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Femarelle (DT56a), a Novel SERM, Effect on the Clotting Time in Normal and Thrombophililic Postmenopausal Women

NCT00883272 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00883272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00883272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Femarelle (DT56a), a Novel SERM, Effect on the Clotting Time in Normal and Thrombophililic Postmenopausal Women
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Completed
Start date
January 31, 2007
Completion date
June 30, 2009
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

menopause, thrombophilia